The crypto betting platform is banned in the U.S. but gained increased prominence during the 2024 U.S. presidential election.

Some investors are more open than others to considering the risk that their money might not have the impact they’re seeking.

In December 2024, NextCure announced that the U.S. Food and Drug Administration had cleared its Investigational New Drug application for LNCB74. LNCB74 is being developed in partnership with LigaChem ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...

WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Keli Walbert will join the Apellis Board of Directors, effective immediately. Ms.

The changing regulatory environment in both the U.S. and the EU will be crucial to increased crypto adoption in 2025, experts ...

RD Lee Capital Partners launched the RDL Hotel Fund I on Vesterr. This gives nonaccredited investors a chance they wouldn't ...

Crypto firm Ripple, which is currently embroiled in a high-profile lawsuit with the U.S. Securities and Exchange Commission, ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Regulatory uncertainty prevented the building of crucial infrastructure for tokenization, but that may soon change.

Michael and David Sztrom, who settled fraud allegations with the SEC in 2022, contend the regulators' "follow on" attempt to ...